Advancing the development of new tuberculosis treatment regimens: The essential role of translational and clinical pharmacology and microbiology
- DOI
- 10.1371/journal.pmed.1002842
- Published
- 2019-07-05
- Container
- PLOS Medicine
- Publisher
- Public Library of Science (PLoS)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1371/journal.pmed.1002842,
title = {Advancing the development of new tuberculosis treatment regimens: The essential role of translational and clinical pharmacology and microbiology},
author = {Kelly E. Dooley and Debra Hanna and Vidya Mave and Kathleen Eisenach and Radojka M. Savic},
year = {2019},
journal = {PLOS Medicine},
doi = {10.1371/journal.pmed.1002842},
url = {https://doi.org/10.1371/journal.pmed.1002842}
}RIS
TY - JOUR TI - Advancing the development of new tuberculosis treatment regimens: The essential role of translational and clinical pharmacology and microbiology AU - Kelly E. Dooley AU - Debra Hanna AU - Vidya Mave AU - Kathleen Eisenach AU - Radojka M. Savic PY - 2019 JO - PLOS Medicine DO - 10.1371/journal.pmed.1002842 UR - https://doi.org/10.1371/journal.pmed.1002842 ER -
APA
Dooley, K. E., Hanna, D., Mave, V., Eisenach, K., & Savic, R. M. (2019). Advancing the development of new tuberculosis treatment regimens: The essential role of translational and clinical pharmacology and microbiology. PLOS Medicine. https://doi.org/10.1371/journal.pmed.1002842
Source records
- crossref · retrieved 2026-09-27T04:00:55.909Z